Ascorbate Plus Buformin in AML: A Metabolic Targeted Treatment

SIMPLE SUMMARY: Acute Myeloid Leukemias (AMLs) are rapidly progressive clonal neoplastic diseases. The overall 5-year survival rate is very poor: less than 5% in older patients aged over 65 years old. Elderly AML patients are often “unfit” for intensive chemotherapy, further highlighting the need of...

Descripción completa

Detalles Bibliográficos
Autores principales: Banella, Cristina, Catalano, Gianfranco, Travaglini, Serena, Pelosi, Elvira, Ottone, Tiziana, Zaza, Alessandra, Guerrera, Gisella, Angelini, Daniela Francesca, Niscola, Pasquale, Divona, Mariadomenica, Battistini, Luca, Screnci, Maria, Ammatuna, Emanuele, Testa, Ugo, Nervi, Clara, Voso, Maria Teresa, Noguera, Nelida Ines
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139619/
https://www.ncbi.nlm.nih.gov/pubmed/35626170
http://dx.doi.org/10.3390/cancers14102565

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139619/
https://www.ncbi.nlm.nih.gov/pubmed/35626170
http://dx.doi.org/10.3390/cancers14102565

Ejemplares similares